The Expected Return from Pharmaceutical Research: Sources of new drugs and the profitability of R & D investment (Evaluative studies ; 19)
This book investigates the sources of new drugs and the profitability of R&D investments in pharmaceuticals. It provides a detailed evaluation of economic returns, drawing on industry data to inform investment decisions in medical research. As part of the Evaluative Studies series, it offers a structured analysis for understanding R&D dynamics.
About This Book
The Expected Return from Pharmaceutical Research analyzes the origins of innovative drugs within the industry. It explores how new pharmaceuticals emerge from various research pathways and assesses their economic viability.
The study delves into the profitability aspects of R&D investments, offering insights into the financial outcomes for pharmaceutical endeavors. It highlights key factors influencing returns in this sector.
Part of the Evaluative Studies series, this work contributes to broader discussions on research evaluation and investment strategies in health-related fields. It maintains a focus on empirical analysis without speculative elements.
Reviews
No reviews yet. Be the first to review this book!